Unlike some vaccines, there’s been so much demand for the new shingles vaccine Shingrix that it’s not always easy to find. It was approved in 2017, and the CDC recommends…
Racial bias among health care providers limits black Americans' odds of receiving a heart transplant, a new study finds. Researchers asked 422 U.S. physicians, nurses and other hospital decision-makers to…
Viga Gemilang was formed in 2019 in Malaysia to develop and commercialize innovativePoint of Care (POC) tests for tropical infectious diseases important to Malaysia and Asia.
Viga Gemilang was formed in 2019 in Malaysia to develop and commercialize innovativePoint of Care (POC) tests for tropical infectious diseases important to Malaysia and Asia.
Viga Gemilang Diagnostics Sdn Bhd (1484331-T)
B-G-8, Rawang Idaman, Jalan Idaman 1,
48000 Rawang, Selangor
03-60924514
012-3133081